Company / Revenue per Share
MADRIGAL PHARMACEUTICALS, INC. Revenue per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$43.55
FY2025
5-year range
$0.00 / $43.55
FY2021-FY2025
Trend
+380.6%
vs FY2024
Sector context
#9 of 154
Health Care
What the data says
Among 154 Health Care companies, MADRIGAL PHARMACEUTICALS, INC. is in the top 6% for revenue per share. Improved from $0.00 to $43.55 over the past 2 years.
Based on SEC 10-K filings.
43.55 in FY2025. Top quartile in the Health Care sector.
Improved from $0.00 to $43.55 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 6% in Health CareTop 6% of 154This company $43.55 Sector average $15.09
▼
+188.6% above sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 380.6% year-over-year.
- Ranks #9 out of 154 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $43.55 | +380.6% |
| FY2024 | $9.06 | - |
| FY2023 | $0.00 | - |
| FY2022 | $0.00 | - |
| FY2021 | $0.00 | - |
| FY2020 | $0.00 | - |
| FY2019 | $0.00 | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026